相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Why imatinib remains an exception of cancer research
Steven D. Horne et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Antonija Kreso et al.
SCIENCE (2013)
Oxidants, antioxidants and the current incurability of metastatic cancers
Jim Watson
OPEN BIOLOGY (2013)
Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study
Serif Ercan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Evolutionary Approaches to Prolong Progression-Free Survival in Breast Cancer
Ariosto S. Silva et al.
CANCER RESEARCH (2012)
Genetic and Epigenetic Heterogeneity in Cancer: The Ultimate Challenge for Drug Therapy
H. H. Heng et al.
CURRENT DRUG TARGETS (2012)
Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer
Stan B. Kaye et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer
Charlotte K. Y. Ng et al.
JOURNAL OF PATHOLOGY (2012)
Evolution of the cancer genome
Lucy R. Yates et al.
NATURE REVIEWS GENETICS (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Extensive genetic variation in somatic human tissues
Maeve O'Huallachain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Tumor progression: Chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution
Sui Huang
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2012)
Using Cell-to-Cell Variability-A New Era in Molecular Biology
Lucas Pelkmans
SCIENCE (2012)
The Predictive Capacity of Personal Genome Sequencing
Nicholas J. Roberts et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Bet Hedging in Yeast by Heterogeneous, Age-Correlated Expression of a Stress Protectant
Sasha F. Levy et al.
PLOS BIOLOGY (2012)
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Robert J. Gillies et al.
NATURE REVIEWS CANCER (2012)
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
T. Van Gorp et al.
BRITISH JOURNAL OF CANCER (2011)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
SEX REDUCES GENETIC VARIATION: A MULTIDISCIPLINARY REVIEW
Root Gorelick et al.
EVOLUTION (2011)
Decoding the genome beyond sequencing: The new phase of genomic research
Henry H. Q. Heng et al.
GENOMICS (2011)
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
Francis Jacob et al.
GYNECOLOGIC ONCOLOGY (2011)
Treatment-Related Mortality With Bevacizumab in Cancer Patients A Meta-analysis
Vishal Ranpura et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model
Amy L. Creekmore et al.
PLOS ONE (2011)
Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors
Ildiko Vereczkey et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
Diverse system stresses: common mechanisms of chromosome fragmentation
J. B. Stevens et al.
CELL DEATH & DISEASE (2011)
Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
David Venet et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger et al.
BRITISH JOURNAL OF CANCER (2010)
Simplistic pathways or complex networks?
Claus Jorgensen et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
The effect of translocation-induced nuclear reorganization on gene expression
Louise Harewood et al.
GENOME RESEARCH (2010)
Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast
Norman Pavelka et al.
NATURE (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Purified human BRCA2 stimulates RAD51-mediated recombination
Ryan B. Jensen et al.
NATURE (2010)
The Origin of Ovarian Cancer - Is It Getting Clearer?
Michael J. Birrer
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
S. L. Cooke et al.
ONCOGENE (2010)
Gene Expression Profile for Predicting Survival in Advanced-Stage Serous Ovarian Cancer Across Two Independent Datasets
Kosuke Yoshihara et al.
PLOS ONE (2010)
Comparison of mitotic cell death by chromosome fragmentation to premature chromosome condensation
Joshua B. Stevens et al.
MOLECULAR CYTOGENETICS (2010)
The genome-centric concept: resynthesis of evolutionary theory
Henry H. Q. Heng
BIOESSAYS (2009)
Genome Based Cell Population Heterogeneity Promotes Tumorigenicity: The Evolutionary Mechanism of Cancer
Christine J. Ye et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas
Katherine V. Clark-Knowles et al.
PLOS ONE (2009)
The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
Patrick O. Brown et al.
PLOS MEDICINE (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Vladimir Nossov et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
The gene-centric concept: a new liability?
Henry H. Q. Heng
BIOESSAYS (2008)
Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation
Olivier Gevaert et al.
BMC CANCER (2008)
The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?
J. K. Chan et al.
BRITISH JOURNAL OF CANCER (2008)
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer
Tomas Bonome et al.
CANCER RESEARCH (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma
Shannon Salvador et al.
GYNECOLOGIC ONCOLOGY (2008)
The conflict between complex systems and reductionism
Henry H. Q. Heng
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The cell of origin of ovarian epithelial tumours
Louis Dubeau
LANCET ONCOLOGY (2008)
Gene-expression profiling in epithelial ovarian cancer
Panagiotis A. Konstantinopoulos et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Angiogenesis as a strategic target for ovarian cancer therapy
Whitney A. Spannuth et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
Mitotic cell death by chromosome fragmentation
Joshua B. Stevens et al.
CANCER RESEARCH (2007)
Cancer genome sequencing: the challenges ahead
Henry H. Q. Heng
BIOESSAYS (2007)
Genomic rearrangements and sporadic disease
James R. Lupski
NATURE GENETICS (2007)
Elimination of altered karyotypes by sexual reproduction preserves species identity
Henry H. Q. Heng
GENOME (2007)
Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours
L. Khalique et al.
JOURNAL OF PATHOLOGY (2007)
Mapping the cancer genome - Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies
Francis S. Collins et al.
SCIENTIFIC AMERICAN (2007)
Cancer as an evolutionary and ecological process
Lauren M. F. Merlo et al.
NATURE REVIEWS CANCER (2006)
Cancer progression by non-clonal chromosome aberrations
Henry H. Q. Heng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer:: A gynecologic cancer intergroup trial of the AGO-OVAR and GINECO
Jacobus Pfisterer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Stochastic cancer progression driven by non-clonal chromosome aberrations
Henry H. Q. Heng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancer
David E. Cohn et al.
GYNECOLOGIC ONCOLOGY (2006)
Systemic therapy for ovarian cancer: Current status and new treatments
Robert F. Ozols
SEMINARS IN ONCOLOGY (2006)
Genetic clonal diversity predicts progression to esophageal adenocarcinoma
CC Maley et al.
NATURE GENETICS (2006)
Clonal and non-clonal chromosome aberrations and genome variation and aberration
Henry H. Q. Heng et al.
GENOME (2006)
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: A prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
A du Bois et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development
JP Capp
BIOESSAYS (2005)
Sequential molecular and cellular events during neoplastic progression: A mouse syngeneic ovarian cancer model
PC Roberts et al.
NEOPLASIA (2005)
Profiling cytogenetic diversity with entropy-based karyotypic analysis
MAA Castro et al.
JOURNAL OF THEORETICAL BIOLOGY (2005)
Statistical behavior of complex cancer karyotypes
M Höglund et al.
GENES CHROMOSOMES & CANCER (2005)
The role of CA125 in clinical practice
EL Moss et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours
NLG Sieben et al.
JOURNAL OF PATHOLOGY (2004)
Clinicopathologic analysis of early-stage sporadic ovarian carcinoma
MM Leitao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report
H Kafali et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2004)
Cytogenetic and molecular genetic characterization of immortalized human ovarian surface epithelial cell lines: consistent loss of chromosome 13 and amplification of chromosome 20
YS Jin et al.
GYNECOLOGIC ONCOLOGY (2004)
Gene expression profiles, of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers
AA Jazaeri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Multicolor spectral karyotyping of serous ovarian adenocarcinoma
PH Rao et al.
GENES CHROMOSOMES & CANCER (2002)
Heterogeneity of ovarian cancer: Relationships among histological group, stage of disease, tumor markers, patient characteristics, and survival
M Pieretti et al.
CANCER INVESTIGATION (2002)
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
E Levy-Lahad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
JB Welsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Development of a syngeneic mouse model for events related to ovarian cancer
KF Roby et al.
CARCINOGENESIS (2000)
分享论文
